Birch Allergy Products

Stallergenes, DBV Entered Into an Agreement for Treatment of Birch Allergy
Oct 22, 2013
France-based biopharmaceutical firms Stallergenes and DBV Technologies have entered into a research and development agreement for the treatment of birch allergy. Stallergenes is specialized in the manufacturing of immunotherapy medicines ...

Tags: Birch Allergy Products, Stallergenes